Oranda Therapeutics Announces Series A Funding Round to support its mission: to improve the lives of patients living with rare disease
DUBLIN–(BUSINESS WIRE)– Oranda Therapeutics, a new Irish headquartered rare disease company with an innovative, fast to market, commercial approach, today announces the launch of their...